Translin binds to the sequences adjacent to the breakpoints of the TLS and CHOP genes in liposarcomas with translocation t(12;16)

被引:24
作者
Hosaka, T
Kanoe, H
Nakayama, T
Murakami, H
Yamamoto, H
Nakamata, T
Tsuboyama, T
Oka, M
Kasai, M
Sasaki, MS
Nakamura, T
Toguchida, J
机构
[1] Kyoto Univ, Inst Frontier Med Sci, Sakyo Ku, Kyoto 6068507, Japan
[2] Kyoto Univ, Dept Orthopaed Surg, Kyoto 6068507, Japan
[3] Kyoto Univ, Ctr Radiat Biol, Kyoto 6068507, Japan
[4] Natl Inst Infect Dis, Dept Immunol, Tokyo 1628640, Japan
关键词
translin; liposarcoma; translocation; mobility-shift assay;
D O I
10.1038/sj.onc.1203943
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Myxoid and round-cell liposarcomas share the translocation t(12;16)(q13;p11) creating the TLS-CHOP fusion gene as a common genetic alteration. We previously reported several unique characteristics of genomic sequences around the breakpoints in the TLS and CHOP loci, and among them was the presence of consensus recognition motifs of Translin, a protein that associates with chromosomal translocations of lymphoid neoplasms. We further extended our search for Translin binding motifs in sequences adjacent to breakpoints and investigated,whether Translin binds to these sequences in vitro by mobility-shift assay. Computer-assisted search found sequences highly homologous (>70%) with Translin binding motifs adjacent to the breakpoints in 10 out of 11 liposarcomas,vith the TLS-CHOP fusion genes. All of 13 oligonucleotides corresponding to the putative binding sequences in these cases bind to Hela cell extract and also recombinant Translin protein, although the binding affinity of each motif showed considerable differences. The DNA-protein complex formation was inhibited by non-labeled competitor or anti-Translin antibody, suggesting the specificity of the complex formation. Considering the high incidence and specific binding property, the presence of Translin binding motif may be one of the important determinants for the location of breakpoints in the TLS and CHOP gents in liposarcomas.
引用
收藏
页码:5821 / 5825
页数:5
相关论文
共 19 条
[1]   A NOVEL GENE, TRANSLIN, ENCODES A RECOMBINATION HOTSPOT BINDING-PROTEIN ASSOCIATED WITH CHROMOSOMAL TRANSLOCATIONS [J].
AOKI, K ;
SUZUKI, K ;
SUGANO, T ;
TASAKA, T ;
NAKAHARA, K ;
KUGE, O ;
OMORI, A ;
KASAI, M .
NATURE GENETICS, 1995, 10 (02) :167-174
[2]   Cloning and sequence analysis of four t(9;11) therapy-related leukemia breakpoints [J].
Atlas, M ;
Head, D ;
Behm, F ;
Schmidt, E ;
Zeleznik-Le, NJ ;
Roe, BA ;
Burian, D ;
Domer, PH .
LEUKEMIA, 1998, 12 (12) :1895-1902
[3]   Crossover breakpoint mapping identifies a subtelomeric hotspot for male meiotic recombination [J].
Badge, RM ;
Yardley, J ;
Jeffreys, AJ ;
Armour, JAL .
HUMAN MOLECULAR GENETICS, 2000, 9 (08) :1239-1244
[4]   Mechanism of action of eukaryotic topoisomerase II and drugs targeted to the enzyme [J].
Burden, DA ;
Osheroff, N .
BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION, 1998, 1400 (1-3) :139-154
[5]   Translin recognition site sequences flank chromosome translocation breakpoints in alveolar rhabdomyosarcoma cell lines [J].
Chalk, JG ;
Barr, FG ;
Mitchell, CD .
ONCOGENE, 1997, 15 (10) :1199-1205
[6]   FUSION OF CHOP TO A NOVEL RNA-BINDING PROTEIN IN HUMAN MYXOID LIPOSARCOMA [J].
CROZAT, A ;
AMAN, P ;
MANDAHL, N ;
RON, D .
NATURE, 1993, 363 (6430) :640-644
[7]   A DNA damage repair mechanism is involved in the origin of chromosomal translocations t(4;11) in primary leukemic cells [J].
Gillert, E ;
Leis, T ;
Repp, R ;
Reichel, M ;
Hösch, A ;
Breitenlohner, I ;
Angermüller, S ;
Borkhardt, A ;
Harbott, J ;
Lampert, F ;
Griesinger, F ;
Greil, J ;
Fey, GH ;
Marschalek, R .
ONCOGENE, 1999, 18 (33) :4663-4671
[8]   The BCR gene recombines preferentially with Alu elements in complex BCR-ABL translocations of chronic myeloid leukaemia [J].
Jeffs, AR ;
Benjes, SM ;
Smith, TL ;
Sowerby, SJ ;
Morris, CM .
HUMAN MOLECULAR GENETICS, 1998, 7 (05) :767-776
[9]   Characteristics of genomic breakpoints in TLS-CHOP translocations in liposarcomas suggest the involvement of Translin and topoisomerase II in the process of translocation [J].
Kanoe, H ;
Nakayama, T ;
Hosaka, T ;
Murakami, H ;
Yamamoto, H ;
Nakashima, Y ;
Tsuboyama, T ;
Nakamura, T ;
Ron, D ;
Sasaki, MS ;
Toguchida, J .
ONCOGENE, 1999, 18 (03) :721-729
[10]  
Kasai M, 1997, J BIOL CHEM, V272, P11402